{"id":"W4402565676","doi":"10.1016/j.annonc.2024.08.2289","title":"LBA48 CCTG BR.31: A global, double-blind placebo-controlled, randomized phase III study of adjuvant durvalumab in completely resected non-small cell lung cancer (NSCLC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Cancer Society; Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Durvalumab; Medicine; Placebo; Internal medicine; Oncology; Lung cancer; Adjuvant; Double blind; non-small cell lung cancer (NSCLC); Cancer; Pathology; Immunotherapy; A549 cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001251826,0.001911307,0.003524235,0.0005457659,0.0004303905,0.0009440621,0.0009900974,0.001581964,0.007673445],"category_scores_gemma":[0.0008436578,0.0007988913,0.001552551,0.000413414,0.001224848,0.0009802642,0.0003836253,0.003404552,0.001592533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006323999,"about_ca_system_score_gemma":0.001383225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001564296,"about_ca_topic_score_gemma":0.004109875,"domain_scores_codex":[0.9996032,0.0001802889,0.00001875671,0.00007908672,0.00002951025,0.00008915803],"domain_scores_gemma":[0.9996287,0.00007874855,0.00006614694,0.00003360633,0.00002484348,0.0001680366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9550608,0.005645373,0.0003365435,0.00114032,0.001147415,0.00003599245,0.00004395909,0.0003934818,0.007782985,0.000185991,0.001938139,0.02628907],"study_design_scores_gemma":[0.9715636,0.02610932,0.0007745993,0.00002215758,0.0002888908,0.00001996027,0.00001277892,0.0002318484,0.0003797597,0.00008151205,0.0005042457,0.00001138577],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663579,0.01340804,0.00208263,0.00141777,0.001139261,0.005794125,0.003287609,0.0008318104,0.005680829],"genre_scores_gemma":[0.9745063,0.005987728,0.002697446,0.001827355,0.0004552873,0.004689571,0.002282921,0.00009850327,0.007454886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007673445,"threshold_uncertainty_score":0.02567023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0812384853944997,"score_gpt":0.4632508735200075,"score_spread":0.3820123881255078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}